Surgical Site Infections Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

Posted on
by

Surgical Site Infections Market Analysis, Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

“Surgical Site Infections (SSI) – Market Insights, Epidemiology, and Market Forecast-2030”

 

DelveInsight has launched a new report on “Surgical Site Infections (SSI) – Market Insights, Epidemiology, and Market Forecast-2030“.

 

DelveInsight’s “Surgical Site Infections (SSI) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Surgical Site Infections (SSI), historical and forecasted epidemiology as well as the Surgical Site Infections (SSI) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some of the key Facts:

  • According to Delveinsight, total SSI cases in the 7MM was estimated to be 1.1 million in 2017 and is expected to grow by 2030.
  • Assessments by DelveInsight’s analysts reveal that the United States accounted for highest incident cases of SSI as compared to EU5 countries and Japan.
  • Among EU5 countries, Germany had the highest incident cases of SSI with 204,225 cases in 2017 while Italy had the lowest incidence.
  • Among the sub-types, superficial SSI had the maximum number of cases followed by organ/space and deep SSI cases.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-market

 

Scope of the report:

  • The report covers the descriptive overview of Surgical Site Infections (SSI), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Surgical Site Infections (SSI) epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Surgical Site Infections (SSI) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Surgical Site Infections (SSI) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Surgical Site Infections (SSI) market

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-market

 

“According to DelveInsight, The total market size for prophylaxis treatment was USD 863 Million in 2017.”

 

Surgical site infection (SSI) is an infection that occurs after surgery in the part of the body where the surgery took place. Surgical site infections can sometimes be superficial infections involving the skin only. Besides, SSI can be more severe and can affect tissues under the skin, organs, or implanted material.

The Centers for Disease Control and Prevention (CDC) categorized surgical site infection (SSI) into three types and given a specific definition of superficial incisional SSI, deep superficial SSI, and organ or space SSI.

In many SSIs, the responsible pathogens originate from the patient’s endogenous flora. The causative pathogens depend on the type of surgery. These infections are mainly associated with bacterial colonization, and bacteria like Staphylococcus, Streptococcus, and Pseudomonas are mainly responsible for them.

These bacteria can infect a surgical wound through various forms of contact, such as from the touch of a contaminated caregiver or surgical instrument, through germs in the air, or through germs that are already on or in the body and then spread into the wound. Symptoms like malaise, fever, pain, erythema, increased warmth, serous or serosanguinous fluid are mainly associated with SSIs.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-market

 

Key Companies Covered:

  • Destiny Pharma
  • Botanix Pharmaceutical
  • Menarini Group
  • And Many Others

 

Drugs Covered:

  • XF-73
  • BTX-1801
  • Delafloxacin
  • And Many Others

 

Table of Contents:

1. Key Insights

2. Executive Summary of Surgical Site Infections (SSI)

3. Competitive Intelligence Analysis for Surgical Site Infections (SSI)

4. Surgical Site Infections (SSI): Market Overview at a Glance

4.1. Surgical Site Infections (SSI) Total Market Share (%) Distribution in 2017

4.2. Surgical Site Infections (SSI) Total Market Share (%) Distribution in 2030

5. Surgical Site Infections (SSI): Disease Background and Overview

5.1. Introduction

5.2. Sign and Symptoms 

5.3. Pathophysiology 

5.4. Risk Factors 

5.5. Diagnosis 

6. Patient Journey

7. Surgical Site Infections (SSI) Epidemiology and Patient Population

7.1. Epidemiology Key Findings

7.2. Assumptions and Rationale: 7MM

7.3. Epidemiology Scenario: 7MM

7.3.1. Surgical Site Infections (SSI) Epidemiology Scenario in the 7MM (2017-2030)

7.4. United States Epidemiology

7.4.1. Surgical Site Infections (SSI) Epidemiology Scenario in the United States (2017-2030)

7.5. EU-5 Country-wise Epidemiology

7.5.1. Germany Epidemiology

7.5.1.1. Surgical Site Infections (SSI) Epidemiology Scenario in Germany (2017-2030)

7.5.2. France Epidemiology

7.5.2.1. Surgical Site Infections (SSI) Epidemiology Scenario in France (2017-2030)

7.5.3. Italy Epidemiology

7.5.3.1. Surgical Site Infections (SSI) Epidemiology Scenario in Italy (2017-2030)

7.5.4. Spain Epidemiology

7.5.4.1. Surgical Site Infections (SSI) Epidemiology Scenario in Spain (2017-2030)

7.5.5. United Kingdom Epidemiology

7.5.5.1. Surgical Site Infections (SSI) Epidemiology Scenario in the United Kingdom (2017-2030)

7.5.6. Japan Epidemiology

7.5.6.1. Surgical Site Infections (SSI) Epidemiology Scenario in Japan (2017-2030)

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Surgical Site Infections (SSI) Treatment and Management

8.2. Surgical Site Infections (SSI) Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Surgical Site Infections (SSI) Treatment

11. Marketed Products

11.1. List of Marketed Products in the 7MM

11.2. Drug Name: Company Name

11.2.1. Product Description

11.2.2. Regulatory Milestones

11.2.3. Other Developmental Activities

11.2.4. Pivotal Clinical Trials

11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

12.1. Key Cross

12.2. Drug Name: Company Name

12.2.1. Product Description

12.2.2. Other Developmental Activities

12.2.3. Clinical Development

12.2.4. Safety and Efficacy

12.2.5. Product Profile

List to be continued in report

13. Surgical Site Infections (SSI): Seven Major Market Analysis

13.1. Key Findings

13.2. Surgical Site Infections (SSI) Market Size in 7MM

13.3. Surgical Site Infections (SSI) Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

15.1.1. Surgical Site Infections (SSI) Total Market Size in the United States

15.1.2. Surgical Site Infections (SSI) Market Size by Therapies in the United States

15.2. EU-5 countries: Market Size and Outlook

15.3. Germany Market Size

15.3.1. Surgical Site Infections (SSI) Total Market Size in Germany

15.3.2. Surgical Site Infections (SSI) Market Size by Therapies in Germany

15.4. France Market Size

15.4.1. Surgical Site Infections (SSI) Total Market Size in France

15.4.2. Surgical Site Infections (SSI) Market Size by Therapies in France

15.5. Italy Market Size

15.5.1. Surgical Site Infections (SSI) Total Market Size in Italy

15.5.2. Surgical Site Infections (SSI) Market Size by Therapies in Italy

15.6. Spain Market Size

15.6.1. Surgical Site Infections (SSI) Total Market Size in Spain

15.6.2. Surgical Site Infections (SSI) Market Size by Therapies in Spain

15.7. United Kingdom Market Size

15.7.1. Surgical Site Infections (SSI) Total Market Size in the United Kingdom

15.7.2. Surgical Site Infections (SSI) Market Size by Therapies in the United Kingdom

15.8. Japan Market Outlook

15.8.1. Japan Market Size

15.8.2. Surgical Site Infections (SSI) Total Market Size in Japan

15.8.3. Surgical Site Infections (SSI) Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Surgical Site Infections (SSI)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Request for Detailed TOC: https://www.delveinsight.com/sample-request/surgical-site-infections-ssi-market

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market